ENLV Enlivex Therapeutics Ltd Forecast, Technical & Fundamental Analysis

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Get AI intraday signals

ENLV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ENLV
(Try 14 days for Free)

View a ticker or compare two or three

Compare

ENLV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ENLV
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

ENLV is expected to report earnings to rise 62.50% to -19 cents per share on December 02

Enlivex Therapeutics Ltd ENLV Stock Earnings Reports

Q3'24

Est.

$-0.19

Q2'24

Beat

by $0.03

Q1'24

Est.

$-0.25

Q4'23

Missed

by $0.21

Q3'23

Est.

$-0.32

The last earnings report on August 19 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 206.45K shares outstanding, the current market capitalization sits at 27.40M.

A.I. Advisor

published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

14 Einstein Street

Phone

+972 26208072

Employees

Web

https://www.enlivex.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
LNTH	115.52	7.54	+6.98%
Lantheus Holdings
ADM	55.30	0.66	+1.21%
Archer Daniels Midland Company
NRGV	2.05	0.01	+0.49%
Energy Vault Holdings
BXC	110.02	0.13	+0.12%
BlueLinx Holdings
BTCS	1.24	-0.02	-1.20%
BTCS

ENLV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with ONCT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then ONCT could also see price increases.

Ticker / NAME	Correlation To ENLV	1D Price Change %
ENLV	100%	+0.74%
ONCT - ENLV	34% Loosely correlated	N/A
APVO - ENLV	34% Loosely correlated	N/A
FATE - ENLV	32% Poorly correlated	+2.53%
VKTX - ENLV	30% Poorly correlated	+0.47%
SLNO - ENLV	29% Poorly correlated	N/A
More